These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30989332)

  • 1. Discordance between doctor and patient assessments and non-adherence to subcutaneous biological drugs.
    Otón T; Carmona L; Urruticoechea-Arana A; Calvo-Alén J; Arteaga MJ; Cea-Calvo L
    Rheumatol Int; 2019 Jun; 39(6):1077-1082. PubMed ID: 30989332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.
    Calvo-Alén J; Monteagudo I; Salvador G; Vázquez-Rodríguez TR; Tovar-Beltrán JV; Vela P; Maceiras F; Bustabad S; Román-Ivorra JA; Díaz-Miguel C; Rosas J; Raya E; Carmona L; Cea-Calvo L; Arteaga MJ; Fernández S; Marras C
    Clin Exp Rheumatol; 2017; 35(3):423-430. PubMed ID: 28032846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Cea-Calvo L; Raya E; Marras C; Salman-Monte TC; Ortiz A; Salvador G; Monteagudo I; Carmona L; Fernandez S; Arteaga MJ; Calvo-Allén J
    Rheumatol Int; 2018 Sep; 38(9):1735-1740. PubMed ID: 29959469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
    Mena-Vazquez N; Manrique-Arija S; Yunquera-Romero L; Ureña-Garnica I; Rojas-Gimenez M; Domic C; Jimenez-Nuñez FG; Fernandez-Nebro A
    Rheumatol Int; 2017 Oct; 37(10):1709-1718. PubMed ID: 28631046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-physician discordance in assessment of adherence to inhaled controller medication: a cross-sectional analysis of two cohorts.
    Jácome C; Pereira AM; Almeida R; Ferreira-Magalhaes M; Couto M; Araujo L; Pereira M; Correia MA; Loureiro CC; Catarata MJ; Maia Santos L; Pereira J; Ramos B; Lopes C; Mendes A; Cidrais Rodrigues JC; Oliveira G; Aguiar AP; Afonso I; Carvalho J; Arrobas A; Coutinho Costa J; Dias J; Todo Bom A; Azevedo J; Ribeiro C; Alves M; Leiria Pinto P; Neuparth N; Palhinha A; Gaspar Marques J; Pinto N; Martins P; Todo Bom F; Alvarenga Santos M; Gomes Costa A; Silva Neto A; Santalha M; Lozoya C; Santos N; Silva D; Vasconcelos MJ; Taborda-Barata L; Carvalhal C; Teixeira MF; Alves RR; Moreira AS; Sofia Pinto C; Morais Silva P; Alves C; Câmara R; Coelho D; Bordalo D; Fernandes RM; Ferreira R; Menezes F; Gomes R; Calix MJ; Marques A; Cardoso J; Emiliano M; Gerardo R; Nunes C; Câmara R; Ferreira JA; Carvalho A; Freitas P; Correia R; Fonseca JA;
    BMJ Open; 2019 Nov; 9(11):e031732. PubMed ID: 31699737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
    Marras C; Monteagudo I; Salvador G; de Toro FJ; Escudero A; Alegre-Sancho JJ; Raya E; Ortiz A; Carmona L; Mestre Y; Cea-Calvo L; Calvo-Alén J
    Rheumatol Int; 2017 Jul; 37(7):1195-1202. PubMed ID: 28516236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity.
    Smolen JS; Strand V; Koenig AS; Szumski A; Kotak S; Jones TV
    Arthritis Res Ther; 2016 May; 18(1):114. PubMed ID: 27209012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance of global assessment by patients and physicians is higher in osteoarthritis than in rheumatoid arthritis: a cross-sectional study from routine care.
    Castrejon I; Shakoor N; Chua JR; Block JA
    Rheumatol Int; 2018 Nov; 38(11):2137-2145. PubMed ID: 30293155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Anti-Tumor Necrosis Factor Therapy Administered Subcutaneously and Associated Factors in Patients With Rheumatoid Arthritis.
    Salaffi F; Carotti M; Di Carlo M; Farah S; Gutierrez M
    J Clin Rheumatol; 2015 Dec; 21(8):419-25. PubMed ID: 26587852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study.
    Balsa A; García de Yébenes MJ; Carmona L;
    Ann Rheum Dis; 2022 Mar; 81(3):327-334. PubMed ID: 34844924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort.
    Markenson JA; Koenig AS; Feng JY; Chaudhari S; Zack DJ; Collier D; Weaver A
    J Clin Rheumatol; 2013 Sep; 19(6):317-23. PubMed ID: 23965479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study.
    Calvo-Alén J; Vela P; Bustabad S; Maceiras F; Carmona L; Cea-Calvo L
    Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):116-119. PubMed ID: 29776887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Monchablon C; Gondé H; Pouplin S; Varin R; Vittecoq O; Lequerré T
    Clin Rheumatol; 2020 Jan; 39(1):207-216. PubMed ID: 31768668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What factors affect discordance between physicians and patients in the global assessment of disease activity in rheumatoid arthritis?
    Cho SK; Sung YK; Choi CB; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim TH; Kim TJ; Koh EM; Lee HS; Lee J; Lee SH; Lee SS; Lee SW; Park SH; Yoo DH; Yoon BY; Bae SC;
    Mod Rheumatol; 2017 Jan; 27(1):35-41. PubMed ID: 27143194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Electronic Health Recording: Evaluation of Electronic Patient-reported Outcome Measures System for Remote Monitoring of Early Rheumatoid Arthritis.
    El Miedany Y; El Gaafary M; Youssef S; Bahlas S; Almedany S; Ahmed I; Palmer D
    J Rheumatol; 2016 Dec; 43(12):2106-2112. PubMed ID: 27633823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patients.
    Tkacz J; Ellis L; Bolge SC; Meyer R; Brady BL; Ruetsch C
    Clin Ther; 2014 May; 36(5):737-47. PubMed ID: 24661783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence on therapy is a major determinant of patient-, physician- and laboratory- reported outcomes in recent-onset rheumatoid arthritis patients.
    Contreras-Yáñez I; Cabiedes J; Villa AR; Rull-Gabayet M; Pascual-Ramos V
    Clin Exp Rheumatol; 2010; 28(5):748-51. PubMed ID: 20863447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue, pain and patient global assessment responses to biological treatment are unpredictable, and poorly inter-connected in individual rheumatoid arthritis patients followed in the daily clinic.
    Madsen OR; Egsmose EM
    Rheumatol Int; 2016 Oct; 36(10):1347-54. PubMed ID: 27449345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between patient global assessment, pain, and fatigue and influence of other clinical disease activity measures in patients with active rheumatoid arthritis.
    Egsmose EL; Madsen OR
    Clin Rheumatol; 2015 Jul; 34(7):1187-94. PubMed ID: 25986917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.